 In 2017, Avista acquired Express Scripts’ United BioSource division and National Spine & Pain Centers (NSPC) from Sentinel Capital Partners, both for undisclosed sums.In 2018, Avista contributed to a $110 million round of financing for Braeburn Pharmaceuticals.Also in 2018, Avista, together with Dana Holdings, purchased Kramer Laboratories, an over-the-counter healthcare platform.